全文获取类型
收费全文 | 394篇 |
免费 | 15篇 |
国内免费 | 18篇 |
专业分类
耳鼻咽喉 | 8篇 |
儿科学 | 19篇 |
妇产科学 | 17篇 |
基础医学 | 30篇 |
口腔科学 | 20篇 |
临床医学 | 39篇 |
内科学 | 89篇 |
皮肤病学 | 41篇 |
神经病学 | 9篇 |
特种医学 | 48篇 |
外科学 | 26篇 |
综合类 | 12篇 |
预防医学 | 21篇 |
眼科学 | 5篇 |
药学 | 20篇 |
肿瘤学 | 23篇 |
出版年
2023年 | 3篇 |
2022年 | 5篇 |
2018年 | 5篇 |
2017年 | 4篇 |
2015年 | 4篇 |
2014年 | 4篇 |
2013年 | 12篇 |
2012年 | 3篇 |
2011年 | 4篇 |
2010年 | 16篇 |
2009年 | 14篇 |
2008年 | 9篇 |
2007年 | 16篇 |
2006年 | 7篇 |
2005年 | 5篇 |
2004年 | 9篇 |
2003年 | 5篇 |
2001年 | 5篇 |
1999年 | 6篇 |
1998年 | 14篇 |
1997年 | 12篇 |
1996年 | 18篇 |
1995年 | 10篇 |
1994年 | 14篇 |
1993年 | 12篇 |
1992年 | 2篇 |
1991年 | 5篇 |
1990年 | 3篇 |
1989年 | 8篇 |
1988年 | 10篇 |
1987年 | 6篇 |
1986年 | 13篇 |
1985年 | 12篇 |
1984年 | 6篇 |
1983年 | 6篇 |
1982年 | 5篇 |
1981年 | 3篇 |
1980年 | 4篇 |
1978年 | 2篇 |
1977年 | 4篇 |
1976年 | 2篇 |
1975年 | 4篇 |
1959年 | 17篇 |
1958年 | 20篇 |
1957年 | 15篇 |
1956年 | 10篇 |
1955年 | 20篇 |
1954年 | 11篇 |
1947年 | 2篇 |
1945年 | 3篇 |
排序方式: 共有427条查询结果,搜索用时 234 毫秒
61.
62.
63.
64.
65.
Measurements of T1 and T2 relaxation values and spin density of the lumbar vertebral bone marrow were performed in 212 patients, and the results were correlated with the patients' age and sex. T1 and T2 relaxation times for bone marrow in the lumbar vertebral bodies showed a progressive decrease with age for both sexes (except for the T2 relaxation values in female patients). The replacement of hematopoietic marrow by fatty marrow could explain the decrease in T1 and T2. The T1 and T2 values were in the same range for the first two age groups (age 1-10 years and age 21-40 years) and became slightly greater for the older female patients (age 51 years and older) than for the older males. This could be due to the loss of bone and mineral content, which is more rapid and significant for women. These normal T1 and T2 values may provide a baseline for future evaluation of diseases involving the lumbar spine. 相似文献
66.
67.
68.
69.
The effect of hepatic dysfunction, defined as abnormal serum bilirubin level, on oral cyclosporin (CSP) pharmacokinetics was examined in 28 marrow transplant patients who received CSP for prophylaxis of graft-v- host disease. Serum CSP concentrations were measured by radioimmunoassay. Forty-one concentration-time courses were studied, divided among patients with no (less than 1.2 mg/dL), mild (1.2 to 2.0 mg/dL), and moderate (2.0 to 5.0 mg/dL) hepatic dysfunction. CSP elimination, as determined by elimination rate constant and clearance, was delayed in patients with moderate hepatic dysfunction compared to those with no hepatic dysfunction (P less than .05). The volume of distribution, lag time for absorption, maximum serum concentration, and time at which the maximum concentration was achieved was not affected by hepatic function. These data indicate that patients with moderate hepatic dysfunction have delayed CSP or CSP metabolite elimination and may be at higher risk for developing CSP-related toxicity. 相似文献
70.